National Research (NASDAQ:NRC) Posts Earnings Results

Key Points

• National Research (NASDAQ:NRC) reported earnings of $0.28 per share for the quarter, with a return on equity of 71.33% and a net margin of 17.14%.
• The stock traded at $13.94, with a market cap of $317.62 million and a PE ratio of 13.53.
• Insider Patrick E. Beans increased his stake by buying 2,500 shares, raising his total ownership to approximately $475,690.77.

National Research (NASDAQ:NRC - Get Free Report) issued its quarterly earnings results on Monday. The company reported $0.28 earnings per share (EPS) for the quarter, Zacks reports. National Research had a return on equity of 71.33% and a net margin of 17.14%.

National Research Stock Performance

Shares of NASDAQ NRC traded up $0.05 during mid-day trading on Monday, hitting $13.94. The stock had a trading volume of 57,938 shares, compared to its average volume of 90,471. The company has a debt-to-equity ratio of 1.98, a quick ratio of 0.54 and a current ratio of 0.54. The company has a 50 day moving average of $15.35 and a two-hundred day moving average of $14.75. National Research has a twelve month low of $9.76 and a twelve month high of $27.07. The firm has a market cap of $317.62 million, a PE ratio of 13.53 and a beta of 0.45.

Insider Activity

In other news, major shareholder Patrick E. Beans bought 2,500 shares of the business's stock in a transaction that occurred on Monday, May 12th. The shares were purchased at an average cost of $13.59 per share, with a total value of $33,975.00. Following the transaction, the insider directly owned 35,003 shares in the company, valued at approximately $475,690.77. The trade was a 7.69% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 8.10% of the stock is currently owned by insiders.

Hedge Funds Weigh In On National Research

Several hedge funds have recently made changes to their positions in the company. AQR Capital Management LLC boosted its holdings in National Research by 168.6% in the first quarter. AQR Capital Management LLC now owns 108,134 shares of the company's stock valued at $1,384,000 after purchasing an additional 67,882 shares during the last quarter. Jane Street Group LLC lifted its stake in National Research by 394.2% in the 1st quarter. Jane Street Group LLC now owns 52,411 shares of the company's stock valued at $671,000 after buying an additional 41,806 shares in the last quarter. Cubist Systematic Strategies LLC acquired a new position in shares of National Research during the 1st quarter worth approximately $118,000. Finally, Strs Ohio purchased a new stake in shares of National Research in the first quarter valued at approximately $33,000. 47.26% of the stock is owned by institutional investors and hedge funds.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.